Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1998 Jul-Sep;4(3):423–426.

Host genes and infectious diseases.

J McNicholl 1
PMCID: PMC2640306  PMID: 9716963

The content is available as a PDF (245.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellamy R., Ruwende C., Corrah T., McAdam K. P., Whittle H. C., Hill A. V. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med. 1998 Mar 5;338(10):640–644. doi: 10.1056/NEJM199803053381002. [DOI] [PubMed] [Google Scholar]
  2. Bloom B. R., Small P. M. The evolving relation between humans and Mycobacterium tuberculosis. N Engl J Med. 1998 Mar 5;338(10):677–678. doi: 10.1056/NEJM199803053381008. [DOI] [PubMed] [Google Scholar]
  3. Carrington M., Kissner T., Gerrard B., Ivanov S., O'Brien S. J., Dean M. Novel alleles of the chemokine-receptor gene CCR5. Am J Hum Genet. 1997 Dec;61(6):1261–1267. doi: 10.1086/301645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Davies P. D. A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle. 1985 Dec;66(4):301–306. doi: 10.1016/0041-3879(85)90068-6. [DOI] [PubMed] [Google Scholar]
  5. Garred P. Chemokine-receptor polymorphisms: clarity or confusion for HIV-1 prognosis? Lancet. 1998 Jan 3;351(9095):2–3. doi: 10.1016/S0140-6736(98)22001-0. [DOI] [PubMed] [Google Scholar]
  6. Gregersen P. K., Silver J., Winchester R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987 Nov;30(11):1205–1213. doi: 10.1002/art.1780301102. [DOI] [PubMed] [Google Scholar]
  7. Kalish R. A., Leong J. M., Steere A. C. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun. 1993 Jul;61(7):2774–2779. doi: 10.1128/iai.61.7.2774-2779.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kaslow R. A., Carrington M., Apple R., Park L., Muñoz A., Saah A. J., Goedert J. J., Winkler C., O'Brien S. J., Rinaldo C. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med. 1996 Apr;2(4):405–411. doi: 10.1038/nm0496-405. [DOI] [PubMed] [Google Scholar]
  9. Kostrikis L. G., Huang Y., Moore J. P., Wolinsky S. M., Zhang L., Guo Y., Deutsch L., Phair J., Neumann A. U., Ho D. D. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med. 1998 Mar;4(3):350–353. doi: 10.1038/nm0398-350. [DOI] [PubMed] [Google Scholar]
  10. McNicholl J. M., Smith D. K., Qari S. H., Hodge T. Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele. Emerg Infect Dis. 1997 Jul-Sep;3(3):261–271. doi: 10.3201/eid0303.970302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Morrison N. A., Qi J. C., Tokita A., Kelly P. J., Crofts L., Nguyen T. V., Sambrook P. N., Eisman J. A. Prediction of bone density from vitamin D receptor alleles. Nature. 1994 Jan 20;367(6460):284–287. doi: 10.1038/367284a0. [DOI] [PubMed] [Google Scholar]
  12. Murphy P. M. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 1996 Jun;7(1):47–64. doi: 10.1016/1359-6101(96)00009-3. [DOI] [PubMed] [Google Scholar]
  13. Mustonen J., Partanen J., Kanerva M., Pietilä K., Vapalahti O., Pasternack A., Vaheri A. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 1996 Jan;49(1):217–221. doi: 10.1038/ki.1996.29. [DOI] [PubMed] [Google Scholar]
  14. Plyusnin A., Hörling J., Kanerva M., Mustonen J., Cheng Y., Partanen J., Vapalahti O., Kukkonen S. K., Niemimaa J., Henttonen H. Puumala hantavirus genome in patients with nephropathia epidemica: correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. J Clin Microbiol. 1997 May;35(5):1090–1096. doi: 10.1128/jcm.35.5.1090-1096.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rook G. A., Steele J., Fraher L., Barker S., Karmali R., O'Riordan J., Stanford J. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology. 1986 Jan;57(1):159–163. [PMC free article] [PubMed] [Google Scholar]
  16. Sainz J., Van Tornout J. M., Loro M. L., Sayre J., Roe T. F., Gilsanz V. Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N Engl J Med. 1997 Jul 10;337(2):77–82. doi: 10.1056/NEJM199707103370202. [DOI] [PubMed] [Google Scholar]
  17. Smith M. W., Dean M., Carrington M., Winkler C., Huttley G. A., Lomb D. A., Goedert J. J., O'Brien T. R., Jacobson L. P., Kaslow R. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science. 1997 Aug 15;277(5328):959–965. doi: 10.1126/science.277.5328.959. [DOI] [PubMed] [Google Scholar]
  18. Steere A. C., Dwyer E., Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med. 1990 Jul 26;323(4):219–223. doi: 10.1056/NEJM199007263230402. [DOI] [PubMed] [Google Scholar]
  19. Wilson A. G., Symons J. A., McDowell T. L., McDevitt H. O., Duff G. W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3195–3199. doi: 10.1073/pnas.94.7.3195. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES